RETRACTED ARTICLE: The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Source abstract
Abstract
We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Daliang Kong, Boda Ying, Jinrui Zhang & Hongliang Ying (2019) The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis. Artificial Cells, Nanomedicine, and Biotechnology, 47(1), 3913-3919, DOI: 10.1080/21691401.2019.1669622Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to provide their original data or to fully respond to our questions regarding the process of the research conducted. Therefore, the authors have agreed to the retraction of the article.We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Phytochemical compounds biological activities · Cancer-related molecular mechanisms research · Ginseng Biological Effects and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedics, China-Japan Union Hospital of Jilin University
Department of Joint Surgery of Orthopaedic Center, The Second Hospital of Jilin University
References
Reference metadata was not supplied for this record.